Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

NCT02191202 · clinicaltrials.gov ↗

COMPLETED

Status

283

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)

Sponsor

Boehringer Ingelheim